跳至主要内容
临床试验/NCT06872645
NCT06872645招募中不适用

Exploring Water-free Sodium Storage

Yale University2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2025年10月3日最近更新:
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
10
试验地点
2
主要终点
Water free Na removal over the 5-day intervention

研究概览

简要总结

The overarching goal of this proposal is to definitively establish if acute water free Na storage and release occurs, if the amount stored/released is of a quantity that is physiologically relevant, and if the location is intracellular vs. extracellular.

详细描述

This study is designed as a an ultra-rigorous inpatient balance study. The main purpose of the study is to determine if significant mobilizable non- extracellular volume (ECV) Na storage occurs in humans. This is a randomized, blinded crossover study. Patients will be randomized to Na free 5% dextrose solution or 1.5% standard peritoneal dialysis (PD) fluid (Dianeal 1.5% low calcium PD solution with standard 132 mmol/L Na and osmolarity of 344 mOsmol/L) and will receive treatment for 5 days, following a 6 week wash out patient will return to undergo 5 days of alternate therapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ESRD Patients actively undergoing PD with a reliably functioning PD catheter
  • Systolic blood pressure > 130 mmHg
  • Serum sodium >135 mmol/L
  • daily urine output < 400ml
  • stable PD prescription for at least 2 months without requirement of 4.25% glucose PD solution
  • PD vintage of at least 6 months
  • Euvolemic as defined by the patient at their dry weight and free of any signs or symptoms of volume overload, per referring nephrologist

排除标准

  • Poorly controlled diabetes with hemoglobin A1C>9%
  • 1 or more episodes of peritonitis in the previous 6 months or active infection of the peritoneal dialysis catheter
  • Anemia with hemoglobin <8g/dL
  • Inability to give written informed consent or follow study protocol.
  • Urinary incontinence
  • Body weight < 60kg
  • gastrointestinal disease that causes diarrhea or expectation of sodium losses in stool.
  • use of amiodarone in the last 6 months (which will interfere with tissue iodine ascertainment).

研究组 & 干预措施

5% dextrose peritoneal dialysis, 2-hour dwell

Experimental

Individuals will receive up to 2 liters of 5% dextrose for peritoneal dialysis during up to a 2-hour dwell for 5 days

干预措施: 5% Dextrose/Water (Drug)

1.5% dextrose peritoneal dialysis, 2-hour dwell

Active Comparator

Individuals will receive up to 2 liters of 1.5% dextrose for peritoneal dialysis during up to a 2-hour dwell for 5 days

干预措施: 1.5% standard PD fluid (Drug)

结局指标

主要结局

Water free Na removal over the 5-day intervention

时间窗: Daily for 5 days

Water free Na removal will be calculated as \[Water Free Na= ((ΔTBW (L) \* serum Na (mmol/L)) - Na balance (mmol)\]. This will be compared between 5% dextrose Na removal period and 1.5% dextrose standard PD neutral Na balance period

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验